• 中国科技期刊卓越行动计划项目资助期刊
  • 中国精品科技期刊
  • EI
  • Scopus
  • CAB Abstracts
  • Global Health
  • 北大核心期刊
  • DOAJ
  • EBSCO
  • 中国核心学术期刊RCCSE A+
  • 中国科技核心期刊CSTPCD
  • JST China
  • FSTA
  • 中国农林核心期刊
  • 中国开放获取期刊数据库COAJ
  • CA
  • WJCI
  • 食品科学与工程领域高质量科技期刊分级目录第一方阵T1
中国精品科技期刊2020
苏晓明,刘小红,王亚雨,等. 甲鱼水解肽对肠道菌群及免疫功能的影响[J]. 食品工业科技,2025,46(19):202−213. doi: 10.13386/j.issn1002-0306.2024110119.
引用本文: 苏晓明,刘小红,王亚雨,等. 甲鱼水解肽对肠道菌群及免疫功能的影响[J]. 食品工业科技,2025,46(19):202−213. doi: 10.13386/j.issn1002-0306.2024110119.
SU Xiaoming, LIU Xiaohong, WANG Yayu, et al. Effects of Pelodiscus sinensis Hydrolyzed Peptides on Gut Microbiota and Immune Function[J]. Science and Technology of Food Industry, 2025, 46(19): 202−213. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2024110119.
Citation: SU Xiaoming, LIU Xiaohong, WANG Yayu, et al. Effects of Pelodiscus sinensis Hydrolyzed Peptides on Gut Microbiota and Immune Function[J]. Science and Technology of Food Industry, 2025, 46(19): 202−213. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2024110119.

甲鱼水解肽对肠道菌群及免疫功能的影响

Effects of Pelodiscus sinensis Hydrolyzed Peptides on Gut Microbiota and Immune Function

  • 摘要: 本试验以甲鱼水解肽为研究对象,探究其对肠道菌群及免疫功能的影响。通过体外肠道模拟系统、依托Caco-2细胞模型,利用16S rRNA(V3-V4)高通量测序技术检测肠道菌群的多样性和组成,HPLC检测发酵液中短链脂肪酸含量,以及qPCR检测Caco-2细胞免疫指标。结果表明,甲鱼水解肽的干预可显著降低(P<0.05)肠道中小杆菌属(Dialister)、活泼瘤胃球菌属(Ruminococcus gnavus)、萨特氏菌属(Sutterella)等促炎菌的相对丰度,同时提升肠道微生物产各短链脂肪酸尤其是丁酸和异戊酸的含量,其中低浓度(5 mg/mL)甲鱼水解肽促进肠道微生物产短链脂肪酸的效果相较于中(25 mg/mL)、高浓度(50 mg/mL)甲鱼水解肽更加稳定。此外,短链脂肪酸对调节肠道免疫功能也具有重要作用。Caco-2细胞模型结果表明:对于正常的Caco-2细胞,甲鱼水解肽能够调节免疫相关基因TLR4NF-κBMD2的表达,促进细胞促炎基因IL-6IL-1βTNF-α和抑炎基因IL-10的表达,进而激活细胞免疫;对于细胞炎症模型,甲鱼水解肽下调促炎基因IL-1β的表达,上调抑炎基因IL-10的表达,降低iNOS的相对表达量,进而缓解细胞的炎症反应。综上所述,甲鱼水解肽可通过调节肠道菌群组成维持肠道稳态、提高免疫能力来发挥益生作用,对探究动物源生物活性肽与肠道微生物的互作关系和营养价值评价体系具有借鉴意义。

     

    Abstract: This study took hydrolyzed peptides from Pelodiscus sinensis as the research object, aiming to investigate their impact on intestinal flora and immune function. Utilizing an in vitro intestinal simulation system and a Caco-2 cell model, 16S rRNA (V3-V4) high-throughput sequencing technology was employed to evaluate the diversity and composition of the intestinal microbiota. Additionally, HPLC was used to quantify the short-chain fatty acid content in the fermentation broth, and qPCR was used to assess the immune factors of Caco-2 cells. The findings revealed that the treatment of P. sinensis hydrolyzed peptides could significantly (P<0.05) decrease the relative abundance of Dialister, Ruminococcus gnavus, and Sutterella in the gut. Furthermore, these peptides enhanced the production of short-chain fatty acids, particularly butyric acid and isovaleric acid, by intestinal microorganisms. Notably, low concentration (5 mg/mL) of P. sinensis hydrolyzed peptides showed a more consistent promotion of short-chain fatty acid production by intestinal microbes compared to the medium (25 mg/mL) and high concentrations (50 mg/mL). Short-chain fatty acids also played a pivotal role in modulating intestinal immune function. The Caco-2 cell model demonstrated that P. sinensis hydrolyzed peptides could regulate the expression of immune-related genes, including TLR4, NF-κB, and MD2, in normal Caco-2 cells. This led to an increase in the expression of pro-inflammatory cytokines (IL-6, IL-1β, TNF-α) and the anti-inflammatory cytokine IL-10, thereby activating cellular immunity. In an inflammatory cellular model, P. sinensis hydrolysate downregulated the expression of pro-inflammatory cytokines (IL-1β) and upregulated anti-inflammatory cytokine IL-10, while also reducing iNOS relative expression level, thereby alleviating the inflammatory response. In conclusion, P. sinensis hydrolyzed peptides can act as prebiotics by modulating the composition to maintain intestinal homeostasis, and enhancing immune function of the intestinal flora, providing valuable insights into the interaction between animal-derived bioactive peptides and intestinal microorganisms, as well as contributing to the nutritional value evaluation system.

     

/

返回文章
返回